Skip to main content
Erschienen in: Neurological Sciences 9/2022

21.05.2022 | Original Article

Multiple sclerosis in patients with hereditary spastic paraplegia: a case report and systematic review

verfasst von: Maria Pia Giannoccaro, Eleonora Matteo, Fiorina Bartiromo, Caterina Tonon, Filippo M. Santorelli, Rocco Liguori, Giovanni Rizzo

Erschienen in: Neurological Sciences | Ausgabe 9/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction

An increasing number of cases of comorbid hereditary spastic paraplegia (HSP) and multiple sclerosis (MS) have been described. We report a patient with the SPG3A form of HSP and features of relapsing-remitting MS (RRMS). We took this opportunity to review the current literature of co-occurring MS and HSP.

Method

The patient underwent clinical, laboratory and neuroimaging evaluations. We performed a literature search for cases of HSP and MS. The 2017 McDonalds Criteria for MS were retrospectively applied to the selected cases.

Results

A 34-year-old woman, presenting a molecular diagnosis of SPG3A, complained subacute sensory-motor symptoms. Spinal MRI disclosed T2-hyperintense lesions at C2, T6 and T4 level, the latter presenting contrast-enhancement. CSF analysis showed oligoclonal bands. She was treated with intravenous high-dose steroids, with symptom resolution. The literature review yielded 13 papers reporting 20 possible cases of MS and HSP. Nine patients (5 M, median age 34) met the 2017 McDonald criteria. Five (25%) received a diagnosis of RRMS and four (20%) of primary progressive MS. Brain MRI showed multiple WM lesions, mostly periventricular. Six of seven cases (85.7%) had spinal cord involvement. Oligoclonal bands were found in 6/8 (75%) patients. Seven patients (77.7%) improved/stabilized on immunotherapy.

Conclusion

This is the first description on the association between SPG3A type of HSP and MS. This report adds to the other reported cases of co-occurring HSPs and MS. Although it remains unclear if this association is casual or causal, clinicians should be aware that an HSP diagnosis does not always exclude a concomitant MS.
Literatur
1.
Zurück zum Zitat Mackay-Sim A (2021) Hereditary spastic paraplegia: from genes, cells and networks to novel pathways for drug discovery. Brain Sci 11:403CrossRef Mackay-Sim A (2021) Hereditary spastic paraplegia: from genes, cells and networks to novel pathways for drug discovery. Brain Sci 11:403CrossRef
2.
Zurück zum Zitat McGinley MP, Goldschmidt CH, Rae-Grant AD (2021) Diagnosis and treatment of multiple sclerosis: a review. JAMA 325:765CrossRef McGinley MP, Goldschmidt CH, Rae-Grant AD (2021) Diagnosis and treatment of multiple sclerosis: a review. JAMA 325:765CrossRef
3.
Zurück zum Zitat DeLuca GC, Ramagopalan SV, Cader MZ et al (2007) The role of hereditary spastic paraplegia related genes in multiple sclerosis: a study of disease susceptibility and clinical outcome. J Neurol 254:1221–1226CrossRef DeLuca GC, Ramagopalan SV, Cader MZ et al (2007) The role of hereditary spastic paraplegia related genes in multiple sclerosis: a study of disease susceptibility and clinical outcome. J Neurol 254:1221–1226CrossRef
4.
Zurück zum Zitat Criscuolo C, Carbone R, Lieto M, Peluso S, Guacci A, Filla A, Quarantelli M, Lanzillo R, Brescia Morra V, De Michele G (2016) SPG5 and multiple sclerosis: clinical and genetic overlap? Acta Neurol Scand 133:410–414CrossRef Criscuolo C, Carbone R, Lieto M, Peluso S, Guacci A, Filla A, Quarantelli M, Lanzillo R, Brescia Morra V, De Michele G (2016) SPG5 and multiple sclerosis: clinical and genetic overlap? Acta Neurol Scand 133:410–414CrossRef
5.
Zurück zum Zitat Jia X, Madireddy L, Caillier S et al (2018) Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis. Ann Neurol 84:51–63CrossRef Jia X, Madireddy L, Caillier S et al (2018) Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis. Ann Neurol 84:51–63CrossRef
6.
Zurück zum Zitat Mead SH (2001) A large family with hereditary spastic paraparesis due to a frame shift mutation of the spastin (SPG4) gene: association with multiple sclerosis in two affected siblings and epilepsy in other affected family members. J Neurol Neurosurg Psychiatry 71:788–791CrossRef Mead SH (2001) A large family with hereditary spastic paraparesis due to a frame shift mutation of the spastin (SPG4) gene: association with multiple sclerosis in two affected siblings and epilepsy in other affected family members. J Neurol Neurosurg Psychiatry 71:788–791CrossRef
7.
Zurück zum Zitat Yazıcı I, Yıldırım N, Zorlu Y (2013) The coexistence of multiple sclerosis and hereditary spastic paraparesis in a patient. Neurol Int 5:6CrossRef Yazıcı I, Yıldırım N, Zorlu Y (2013) The coexistence of multiple sclerosis and hereditary spastic paraparesis in a patient. Neurol Int 5:6CrossRef
8.
Zurück zum Zitat Boucher JJ, Counihan TJ (2020) Co-incident primary progressive multiple sclerosis and hereditary spastic paraplegia (SPG4) – a case report. Mult Scler Relat Disord 44:102375CrossRef Boucher JJ, Counihan TJ (2020) Co-incident primary progressive multiple sclerosis and hereditary spastic paraplegia (SPG4) – a case report. Mult Scler Relat Disord 44:102375CrossRef
9.
Zurück zum Zitat Bellinvia A, Pastò L, Niccolai C et al (2020) A new paraplegin mutation in a patient with primary progressive multiple sclerosis. Mult Scler Relat Disord 44:102302CrossRef Bellinvia A, Pastò L, Niccolai C et al (2020) A new paraplegin mutation in a patient with primary progressive multiple sclerosis. Mult Scler Relat Disord 44:102302CrossRef
10.
Zurück zum Zitat Laurencin C, Rascle L, Cotton F, Grosset-Janin C, Bernard E, Depienne C, Vukusic S, Thobois S (2016) A rare case of SPG11 mutation with multiple sclerosis. Rev Neurol (Paris) 172:389–391CrossRef Laurencin C, Rascle L, Cotton F, Grosset-Janin C, Bernard E, Depienne C, Vukusic S, Thobois S (2016) A rare case of SPG11 mutation with multiple sclerosis. Rev Neurol (Paris) 172:389–391CrossRef
11.
Zurück zum Zitat Maggi P, Absinta M, Sati P et al (2020) The “central vein sign” in patients with diagnostic “red flags” for multiple sclerosis: a prospective multicenter 3T study. Mult Scler J 26:421–432CrossRef Maggi P, Absinta M, Sati P et al (2020) The “central vein sign” in patients with diagnostic “red flags” for multiple sclerosis: a prospective multicenter 3T study. Mult Scler J 26:421–432CrossRef
12.
Zurück zum Zitat Dürr A, Davoine C-S, Paternotte C et al (1996) Phenotype of autosomal dominant spastic paraplegia linked to chromosome 2. Brain 119:1487–1496CrossRef Dürr A, Davoine C-S, Paternotte C et al (1996) Phenotype of autosomal dominant spastic paraplegia linked to chromosome 2. Brain 119:1487–1496CrossRef
13.
Zurück zum Zitat Rubegni A, Battisti C, Tessa A, Cerase A, Doccini S, Malandrini A, Santorelli FM, Federico A (2017) SPG2 mimicking multiple sclerosis in a family identified using next generation sequencing. J Neurol Sci 375:198–202CrossRef Rubegni A, Battisti C, Tessa A, Cerase A, Doccini S, Malandrini A, Santorelli FM, Federico A (2017) SPG2 mimicking multiple sclerosis in a family identified using next generation sequencing. J Neurol Sci 375:198–202CrossRef
14.
Zurück zum Zitat Warshawsky I, Rudick RA, Staugaitis SM, Natowicz MR (2005) Primary progressive multiple sclerosis as a phenotype of a PLP1 gene mutation. Ann Neurol 58:470–473CrossRef Warshawsky I, Rudick RA, Staugaitis SM, Natowicz MR (2005) Primary progressive multiple sclerosis as a phenotype of a PLP1 gene mutation. Ann Neurol 58:470–473CrossRef
15.
Zurück zum Zitat Romagnolo A, Masera S, Mattioda A, Superti G, Santorelli FM, Mongini T, Pinessi L, Cavalla P (2014) Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation. Eur J Neurol 21:e14–e15CrossRef Romagnolo A, Masera S, Mattioda A, Superti G, Santorelli FM, Mongini T, Pinessi L, Cavalla P (2014) Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation. Eur J Neurol 21:e14–e15CrossRef
16.
Zurück zum Zitat Mukai M, Koh K, Ohnuki Y, Nagata E, Takiyama Y, Takizawa S (2018) Novel SPG11 mutations in a patient with symptoms mimicking multiple sclerosis. Intern Med 57:3183–3186CrossRef Mukai M, Koh K, Ohnuki Y, Nagata E, Takiyama Y, Takizawa S (2018) Novel SPG11 mutations in a patient with symptoms mimicking multiple sclerosis. Intern Med 57:3183–3186CrossRef
17.
Zurück zum Zitat Gorman MP, Golomb MR, Walsh LE, Hobson GM, Garbern JY, Kinkel RP, Darras BT, Urion DK, Eksioglu YZ (2007) Steroid-responsive neurologic relapses in a child with a proteolipid protein-1 mutation. Neurology 68:1305–1307CrossRef Gorman MP, Golomb MR, Walsh LE, Hobson GM, Garbern JY, Kinkel RP, Darras BT, Urion DK, Eksioglu YZ (2007) Steroid-responsive neurologic relapses in a child with a proteolipid protein-1 mutation. Neurology 68:1305–1307CrossRef
19.
Zurück zum Zitat Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162–173CrossRef Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162–173CrossRef
20.
Zurück zum Zitat Zhao X, Alvarado D, Rainier S et al (2001) Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia. Nat Genet 29:326–331CrossRef Zhao X, Alvarado D, Rainier S et al (2001) Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia. Nat Genet 29:326–331CrossRef
21.
Zurück zum Zitat Battaglia MA, Bezzini D (2017) Estimated prevalence of multiple sclerosis in Italy in 2015. Neurol Sci 38:473–479CrossRef Battaglia MA, Bezzini D (2017) Estimated prevalence of multiple sclerosis in Italy in 2015. Neurol Sci 38:473–479CrossRef
22.
Zurück zum Zitat Ruano L, Melo C, Silva MC, Coutinho P (2014) The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology 42:174–183CrossRef Ruano L, Melo C, Silva MC, Coutinho P (2014) The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology 42:174–183CrossRef
23.
Zurück zum Zitat Solomon AJ, Naismith RT, Cross AH (2019) Misdiagnosis of multiple sclerosis. Neurology 92:26–33CrossRef Solomon AJ, Naismith RT, Cross AH (2019) Misdiagnosis of multiple sclerosis. Neurology 92:26–33CrossRef
24.
Zurück zum Zitat da Graça FF, de Rezende TJR, Vasconcellos LFR, Pedroso JL, Barsottini OGP, França MC (2019) Neuroimaging in hereditary spastic paraplegias: current use and future perspectives. Front Neurol 9:1117CrossRef da Graça FF, de Rezende TJR, Vasconcellos LFR, Pedroso JL, Barsottini OGP, França MC (2019) Neuroimaging in hereditary spastic paraplegias: current use and future perspectives. Front Neurol 9:1117CrossRef
25.
Zurück zum Zitat Servelhere KR, Casseb RF, de Lima FD, Rezende TJR, Ramalho LP, França MC (2021) Spinal cord gray and white matter damage in different hereditary spastic paraplegia subtypes. Am J Neuroradiol 42:610–615CrossRef Servelhere KR, Casseb RF, de Lima FD, Rezende TJR, Ramalho LP, França MC (2021) Spinal cord gray and white matter damage in different hereditary spastic paraplegia subtypes. Am J Neuroradiol 42:610–615CrossRef
26.
Zurück zum Zitat Weisfeld-Adams JD, Katz Sand IB, Honce JM, Lublin FD (2015) Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis. Brain 138:517–539CrossRef Weisfeld-Adams JD, Katz Sand IB, Honce JM, Lublin FD (2015) Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis. Brain 138:517–539CrossRef
28.
Zurück zum Zitat Heneka MT, Kummer MP, Latz E (2014) Innate immune activation in neurodegenerative disease. Nat Rev Immunol 14:463–477CrossRef Heneka MT, Kummer MP, Latz E (2014) Innate immune activation in neurodegenerative disease. Nat Rev Immunol 14:463–477CrossRef
29.
Zurück zum Zitat Bergqvist C, Hemery F, Ferkal S, Wolkenstein P (2020) Neurofibromatosis I and multiple sclerosis. Orphanet J Rare Dis 15:186CrossRef Bergqvist C, Hemery F, Ferkal S, Wolkenstein P (2020) Neurofibromatosis I and multiple sclerosis. Orphanet J Rare Dis 15:186CrossRef
30.
Zurück zum Zitat Palace J (2009) Multiple sclerosis associated with Leber’s Hereditary Optic Neuropathy. J Neurol Sci 286:24–27CrossRef Palace J (2009) Multiple sclerosis associated with Leber’s Hereditary Optic Neuropathy. J Neurol Sci 286:24–27CrossRef
Metadaten
Titel
Multiple sclerosis in patients with hereditary spastic paraplegia: a case report and systematic review
verfasst von
Maria Pia Giannoccaro
Eleonora Matteo
Fiorina Bartiromo
Caterina Tonon
Filippo M. Santorelli
Rocco Liguori
Giovanni Rizzo
Publikationsdatum
21.05.2022
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 9/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-022-06145-1

Weitere Artikel der Ausgabe 9/2022

Neurological Sciences 9/2022 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.